FBT
$171.91
First Trust NYSE Arca Biotechnology Index Fund
Fund Family: First Trust Exchange-Traded Fund
1 Month
+3.57%
YTD
+1.42%
1 Year
+1.42%
3 Year
+25.77%
Top 10 Holdings (45.1% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Corcept Therapeutics Inc. | HTD | Financial Services | 7.70% |
| 2 | BeiGene Ltd | ONC | Unknown | 5.18% |
| 3 | Intra-Cellular Therapies Inc | ITCIEUR | Unknown | 4.67% |
| 4 | Gilead Sciences Inc | GILD | Manufacturing | 4.19% |
| 5 | Halozyme Therapeutics, Inc. | HALO | Manufacturing | 4.06% |
| 6 | Amgen Inc | AMGN | Manufacturing | 3.99% |
| 7 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 3.98% |
| 8 | MOTION FINCO SARL | ALKS | Manufacturing | 3.95% |
| 9 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.81% |
| 10 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 3.53% |
Fund Information
| Net Assets | $1.11B | Expense Ratio | N/A |
| Total Holdings | 32 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | First Trust Exchange-Traded Fund |
*Annual fee per $10,000 invested